Cancers, Volume 11, Issue 1
2019 January - 126 articles
Cover Story: NK cells are cytotoxic immune cells with an innate capability of eliminating cancer cells. They are present in all steps of the metastatic cascade and play a central role in the control of metastasis. However, metastatic cells develop the most refined de facto immunosubversive mechanisms, thereby increasing the probability of malignant dissemination. The key role of NK cells in the control of metastasis provides an opportunity for immunotherapeutic intervention in cancer patients. Current therapeutic approaches include the adoptive transfer of NK cells, the boosting of NK cell activity with stimulating cytokines and drugs, the redirection of NK cell activity against metastatic cells, and the release of evasion mechanisms dampening NK cell immunosurveillance. Now, the challenge is to translate the increasing amount of preclinical cancer research into new therapeutic strategies. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.